LENZ Therapeutics (LENZ) Change in Cash (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly Change in Cash came in at -$407000.0 in Q1 2026, down 114.11% year-on-year from $2.9 million in Q1 2025, and down 85.0% on a QoQ basis from -$220000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Change in Cash (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Change in Cash data on file, last reported at -$407000.0 in Q1 2026.
- On a quarterly basis, Change in Cash fell 114.11% year-over-year to -$407000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 100.91% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 133.0% from the prior year.
- Change in Cash for Q1 2026 stood at -$407000.0, down from -$220000.0 in the prior quarter.
- Over the last five years, Change in Cash for LENZ reached as high as $165.3 million in Q1 2024 and fell as low as -$191.9 million in Q1 2022.
- Historically, Change in Cash has averaged -$20.5 million across 5 years, with a median of -$12.3 million in 2025.
- Across the five-year window, Change in Cash tumbled 246.27% in 2022 and jumped 136.67% in 2023, its largest moves.
- Year by year, Change in Cash stood at -$8.7 million in 2022, then grew by 11.0% to -$7.7 million in 2023, then sank by 170.99% to -$20.9 million in 2024, then surged by 98.95% to -$220000.0 in 2025, then plunged by 85.0% to -$407000.0 in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$407000.0 in Q1 2026, -$220000.0 in Q4 2025, and -$12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 | -407,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -407,000.00 |
| Dec 31, 2025 | -220,000.00 |
| Sep 30, 2025 | -12.32 Mn |
| Jun 30, 2025 | 14.57 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | -20.89 Mn |
| Sep 30, 2024 | -42.99 Mn |
| Jun 30, 2024 | -116.32 Mn |
| Mar 31, 2024 | 165.33 Mn |
| Dec 31, 2023 | -7.71 Mn |
| Sep 30, 2023 | -31.57 Mn |
| Jun 30, 2023 | -40.40 Mn |
| Mar 31, 2023 | 70.38 Mn |
| Dec 31, 2022 | -8.66 Mn |
| Sep 30, 2022 | -18.78 Mn |
| Jun 30, 2022 | -109.90 Mn |
| Mar 31, 2022 | -191.91 Mn |
| Dec 31, 2021 | -16.26 Mn |
| Sep 30, 2021 | 12.84 Mn |
| Jun 30, 2021 | 204.95 Mn |